(36B3) iShares MSCI Europe SRI - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BGDPWW94 • Europe Large-Cap Blend Equity
36B3: Stocks, Bonds, European, Equities, Investments
URL: http://www.blackrock.com Index: Morningstar DM Eur TME NR EUR
Additional Sources for 36B3 ETF
36B3 ETF Overview
| Market Cap in USD | 276m |
| Category | Europe Large-Cap Blend Equity |
| TER | 0.20% |
| IPO / Inception | 2018-12-06 |
36B3 ETF Ratings
| Growth 5y | 47.3% |
| Fundamental | - |
| Dividend | 56.4% |
| Rel. Strength Industry | -1.69 |
| Analysts | - |
| Fair Price Momentum | 7.16 EUR |
| Fair Price DCF | - |
36B3 Dividends
| Dividend Yield 12m | 2.34% |
| Yield on Cost 5y | 3.35% |
| Annual Growth 5y | 12.35% |
| Payout Consistency | 94.5% |
36B3 Growth Ratios
| Growth Correlation 3m | 63.4% |
| Growth Correlation 12m | 20.2% |
| Growth Correlation 5y | 82.8% |
| CAGR 5y | 7.68% |
| CAGR/Max DD 5y | 0.26 |
| Sharpe Ratio 12m | 0.31 |
| Alpha | -5.91 |
| Beta | 0.59 |
| Volatility | 10.66% |
| Current Volume | 104.3k |
| Average Volume 20d | 80.9k |
What is the price of 36B3 stocks?
As of February 23, 2025, the stock is trading at EUR 7.75 with a total of 104,310 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +2.65%, over three months by +5.77% and over the past year by +6.77%.
As of February 23, 2025, the stock is trading at EUR 7.75 with a total of 104,310 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +2.65%, over three months by +5.77% and over the past year by +6.77%.
Is iShares MSCI Europe SRI a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares MSCI Europe SRI (XETRA:36B3) is currently (February 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.33 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of 36B3 as of February 2025 is 7.16. This means that 36B3 is currently overvalued and has a potential downside of -7.61%.
Partly, yes. Based on ValueRay Analyses, iShares MSCI Europe SRI (XETRA:36B3) is currently (February 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.33 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of 36B3 as of February 2025 is 7.16. This means that 36B3 is currently overvalued and has a potential downside of -7.61%.
Is 36B3 a buy, sell or hold?
iShares MSCI Europe SRI has no consensus analysts rating.
iShares MSCI Europe SRI has no consensus analysts rating.
What are the forecast for 36B3 stock price target?
According to ValueRays Forecast Model, 36B3 iShares MSCI Europe SRI will be worth about 8.4 in February 2026. The stock is currently trading at 7.75. This means that the stock has a potential upside of +7.74%.
According to ValueRays Forecast Model, 36B3 iShares MSCI Europe SRI will be worth about 8.4 in February 2026. The stock is currently trading at 7.75. This means that the stock has a potential upside of +7.74%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8.4 | 7.7% |